C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
Paul M. Ridker(Brigham and Women's Hospital), Nader Rifai(Boston Children's Hospital), Nancy R. Cook(Brigham and Women's Hospital), Julie E. Buring(Brigham and Women's Hospital)
Cited by 2,293
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k